Dichotomising HLA-G expression based on positive expression (> 0% positive cells) or a 5%-cut-off has previously been used in prognostic biomarker studies on patients with colorectal cancer [15–17, 36, 37]. The gene discussed is HLA-G; the disease is colorectal cancer.